Effects of Esketamine at Subanesthetic Dose on Emergence Delirium in Preschool Children Undergoing Ambulatory Laparoscopic Surgery
NCT ID: NCT06789185
Last Updated: 2025-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
96 participants
INTERVENTIONAL
2025-02-07
2025-05-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Morphine or Ketamine for Analgesia
NCT06835504
Safety and Efficacy Evaluation of S (+) - Ketamine in Children
NCT04834427
Sub-dissociative Ketamine for the Management of Acute Pediatric Pain
NCT01951963
The Efficacy and Safety of Chloroprocaine 1% and 2% in Pediatric Population
NCT03918798
Use of Caudal Anesthesia Supplemented With Morphine in Children Undergoing Renal Surgery
NCT01869036
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group S1 (0.1mg/kg esketamine)
0.1mg/kg esketamine
Intravenous injection 0.1mg/kg esketamine about 5min before the end of the surgery
group S2 (0.2mg/kg esketamine)
0.2mg/kg esketamine
Intravenous injection 0.2mg/kg esketamine about 5min before the end of the surgery
group C (0.1ml/kg Normal saline)
0.1ml/kg normal saline
Intravenous injection 0.1ml/kg normal saline about 5min before the end of the surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
0.1mg/kg esketamine
Intravenous injection 0.1mg/kg esketamine about 5min before the end of the surgery
0.2mg/kg esketamine
Intravenous injection 0.2mg/kg esketamine about 5min before the end of the surgery
0.1ml/kg normal saline
Intravenous injection 0.1ml/kg normal saline about 5min before the end of the surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. aged 24\~71 months
3. American Society of Anesthesiologists Physical Status I or II
4. body mass index for age between the 5th and 85th percentiles
Exclusion Criteria
2. abnormal liver or kidney function
3. glaucoma or neurological disorders
4. cardiovascular or endocrine dysfunction
5. asthma or respiratory infection in the last 2 weeks
6. developmental delay
24 Months
71 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qiu jinpeng
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Qiu jinpeng
attending anesthesiologist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Children's Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-IRB-0377-P-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.